Dabigatran reduces mortality in patients with atrial fibrillation and obesity: Study MD Editorial Team30 Sep 2021 3:30 AM GMTUSA: According to a study conducted by Cheng-Wei Huang and peers, dabigatran was effective in reducing the risk of thromboembolism and mortality in...
Warfarin use in cancer-associated thrombosis tied to improved overall survival: Study MD Editorial Team29 Sep 2021 3:30 AM GMTUSA: A recent study reported warfarin use to be associated with improved overall survival (OS) versus low-molecular-weight (LMWH) in the treatment of...
Apixaban linked to lesser adverse events in AF elderly patients with frailty: Study Medha Baranwal21 July 2021 4:00 AM GMTUSA: Apixaban compared with warfarin is associated with a lower rate of adverse events across all frailty levels in older adults with atrial...
DOACs associated with lower mortality in comparison to Warfarin, Finds study Dr. Nandita Mohan29 Jun 2021 4:00 AM GMTAmong US nursing home residents, the direct-acting oral anticoagulants (DOACs) were each associated with lower mortality versus warfarin, according...
DOACs Better than Warfarin in Patients with Valvular Atrial Fibrillation, finds study MD Bureau31 March 2021 3:56 AM GMTAtrial fibrillation (AF) affects 5.2 million Americans, results in 158 000 deaths annually, and increases the risk for stroke. Although warfarin has...
Rivaroxaban as good as warfarin in AF patients with bioprosthetic mitral valves: RIVER trial Dr Satabdi Saha17 Nov 2020 9:30 AM GMTResearchers have found in The RIVER trial, the largest study that anticoagulant rivaroxaban worked as well as the standard anticoagulant medication...
DOACs May Confer Lower Fracture Risk Than Warfarin in Afib, confirms study Dr. Kamal Kant Kohli19 May 2020 10:51 AM GMTDirect oral anticoagulants (DOACs) are associated with lower fracture risk than warfarin in patients with atrial fibrillation (AF) finds a new...
